Invesco’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-41,516
| Closed | -$3.86M | – | 4155 |
|
|
2021
Q4 | $3.86M | Sell |
41,516
-3,739
| -8% | -$246K | ﹤0.01% | 2526 |
|
|
2021
Q3 | $2.69M | Sell |
45,255
-8,689
| -16% | -$513K | ﹤0.01% | 2683 |
|
|
2021
Q2 | $3.68M | Buy |
53,944
+6,869
| +15% | +$448K | ﹤0.01% | 2584 |
|
|
2021
Q1 | $3.27M | Buy |
47,075
+10,616
| +29% | +$817K | ﹤0.01% | 2569 |
|
|
2020
Q4 | $2.8M | Sell |
36,459
-4,573
| -11% | -$343K | ﹤0.01% | 2472 |
|
|
2020
Q3 | $3.07M | Sell |
41,032
-2,419
| -6% | -$161K | ﹤0.01% | 2267 |
|
|
2020
Q2 | $2.73M | Sell |
43,451
-170,624
| -80% | -$9.39M | ﹤0.01% | 2316 |
|
|
2020
Q1 | $8.99M | Buy |
214,075
+136,713
| +177% | +$6.27M | ﹤0.01% | 1583 |
|
|
2019
Q4 | $3.51M | Sell |
77,362
-130,024
| -63% | -$6.15M | ﹤0.01% | 2365 |
|
|
2019
Q3 | $9.49M | Sell |
207,386
-16,233
| -7% | -$912K | ﹤0.01% | 1767 |
|
|
2019
Q2 | $13.1M | Buy |
223,619
+217,643
| +3,642% | +$11.2M | ﹤0.01% | 1637 |
|
|
2019
Q1 | $268K | Buy |
+5,976
| New | +$274K | ﹤0.01% | 3527 |
|
|
2018
Q4 | – | Sell |
-259,760
| Closed | -$12M | – | 3901 |
|
|
2018
Q3 | $12M | Buy |
259,760
+139,369
| +116% | +$5.65M | ﹤0.01% | 1596 |
|
|
2018
Q2 | $5.25M | Sell |
120,391
-152,408
| -56% | -$6.55M | ﹤0.01% | 2107 |
|
|
2018
Q1 | $10.8M | Sell |
272,799
-7,277
| -3% | -$283K | ﹤0.01% | 1494 |
|
|
2017
Q4 | $9.52M | Buy |
280,076
+221,140
| +375% | +$6.3M | ﹤0.01% | 1603 |
|
|
2017
Q3 | $1.5M | Buy |
+58,936
| New | +$1.35M | ﹤0.01% | 2765 |
|
|
2017
Q2 | – | Sell |
-6,896
| Closed | -$101K | – | 3734 |
|
|
2017
Q1 | $101K | Buy |
6,896
+836
| +14% | +$12.4K | ﹤0.01% | 3653 |
|
|
2016
Q4 | $86K | Buy |
6,060
+394
| +7% | +$6.1K | ﹤0.01% | 3617 |
|
|
2016
Q3 | $99K | Buy |
5,666
+22
| +0.4% | +$365 | ﹤0.01% | 3592 |
|
|
2016
Q2 | $97K | Buy |
5,644
+2,435
| +76% | +$43.5K | ﹤0.01% | 3626 |
|
|
2016
Q1 | $63K | Sell |
3,209
-213
| -6% | -$3.41K | ﹤0.01% | 3651 |
|
|
2015
Q4 | $65K | Buy |
3,422
+114
| +3% | +$2.33K | ﹤0.01% | 3679 |
|
|
2015
Q3 | $63K | Sell |
3,308
-44
| -1% | -$1.49K | ﹤0.01% | 3718 |
|
|
2015
Q2 | $156K | Buy |
+3,352
| New | +$145K | ﹤0.01% | 3787 |
|
|
2015
Q1 | – | Sell |
-296,667
| Closed | -$10.3M | – | 4092 |
|
|
2014
Q4 | $10.3M | Buy |
296,667
+29,675
| +11% | +$1.2M | ﹤0.01% | 1521 |
|
|
2014
Q3 | $11.2M | Buy |
266,992
+117,329
| +78% | +$5.24M | ﹤0.01% | 1487 |
|
|
2014
Q2 | $8.77M | Sell |
149,663
-35,059
| -19% | -$2.21M | ﹤0.01% | 1616 |
|
|
2014
Q1 | $11.6M | Buy |
184,722
+62,686
| +51% | +$4.16M | ﹤0.01% | 1451 |
|
|
2013
Q4 | $7.14M | Buy |
122,036
+34,037
| +39% | +$1.78M | ﹤0.01% | 1759 |
|
|
2013
Q3 | $4.64M | Buy |
+87,999
| New | +$5.91M | ﹤0.01% | 1986 |
|
Invesco's ARNA Position: Q1 2022 in Review
Invesco sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 41,516 shares — an estimated $3.86M sold.
Invesco first reported a position in ARNA in Q3 2013 and held it in 31 quarters. The position peaked at $13.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Invesco reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Invesco sold 41,516 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.86M.
- Invesco first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 31 quarters.
- Invesco's Arena Pharmaceuticals Inc position peaked at $13.1M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.